>
ChromoGenics AB logo

CHRO TO3 - ChromoGenics AB Share Price

SEK3.2 -0.0  -0.6%

Last Trade - 14/04/21

Sector
Consumer Cyclicals
Size
Micro Cap
Market Cap £13.1m
Enterprise Value £9.95m
Revenue £1.25m
Position in Universe 1507th / 1829
Bullish
Bearish
Unlock CHRO TO3 Revenue
Momentum
Relative Strength (%)
1m -6.25%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -35.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 3.04 6.86 11.2 45.2 14.6
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,ChromoGenics AB revenues decreased 68% to SEK14.6M. Netloss decreased 20% to SEK62.5M. Revenues reflect a decreasein demand for the Company's products and services due tounfavorable market conditions. Lower net loss reflectsOther External Expenses decrease of 29% to SEK27.3M(expense), Personnel Costs decrease of 8% to SEK25M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CHRO TO3 Revenue Unlock CHRO TO3 Revenue

Net Income

CHRO TO3 Net Income Unlock CHRO TO3 Revenue

Normalised EPS

CHRO TO3 Normalised EPS Unlock CHRO TO3 Revenue

PE Ratio Range

CHRO TO3 PE Ratio Range Unlock CHRO TO3 Revenue

Dividend Yield Range

CHRO TO3 Dividend Yield Range Unlock CHRO TO3 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CHRO TO3 EPS Forecasts Unlock CHRO TO3 Revenue
Profile Summary

ChromoGenics AB is a Sweden-based company, which develops, manufactures and markets foil-based products with controllable optical properties and conducts related business. The Company’s primary product is ConverLight, which is an electrochromic glass with dynamic solar control properties. This glass enables control of light influx to tone down the light and energy admission in various parts of property or premises. The glass is suitable for new construction, reconstruction and renovation and offers ultraviolet protection that reduces risk of fading interiors. The Company distributes ConverLight to commercial installation companies in Sweden and Norway. The main shareholders in the Company are K-Svets Venture AB and New Energy Solutions II K/S.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Public Since March 23, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Consumer Cyclicals
Industry Homebuilding & Construction Supplies
Index
Exchange OMX Nordic Exchange Stockholm (Dual Listing)
Shares in Issue 16,976,019
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CHRO TO3 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CHRO TO3
Upcoming Events for CHRO TO3
Frequently Asked Questions for ChromoGenics AB
What is the ChromoGenics AB share price?

As of 14/04/21, shares in ChromoGenics AB are trading at SEK3.2, giving the company a market capitalisation of £13.1m. This share price information is delayed by 15 minutes.

How has the ChromoGenics AB share price performed this year?

Shares in ChromoGenics AB are currently trading at SEK3.2 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the ChromoGenics AB price has moved by % over the past year.

What are the analyst and broker recommendations for ChromoGenics AB?

There are no analysts currently covering ChromoGenics AB.

When will ChromoGenics AB next release its financial results?

ChromoGenics AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the ChromoGenics AB dividend yield?

ChromoGenics AB does not currently pay a dividend.

Does ChromoGenics AB pay a dividend?

ChromoGenics AB does not currently pay a dividend.

When does ChromoGenics AB next pay dividends?

ChromoGenics AB does not currently pay a dividend.

How do I buy ChromoGenics AB shares?

To buy shares in ChromoGenics AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of ChromoGenics AB?

Shares in ChromoGenics AB are currently trading at SEK3.2, giving the company a market capitalisation of £13.1m.

Where are ChromoGenics AB shares listed? Where are ChromoGenics AB shares listed?

Here are the trading details for ChromoGenics AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: CHRO TO3
What kind of share is ChromoGenics AB?

Based on an overall assessment of its quality, value and momentum, ChromoGenics AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a ChromoGenics AB share price forecast 2021?

We were not able to load any forecast data for ChromoGenics AB.

How can I tell whether the ChromoGenics AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ChromoGenics AB. Over the past six months, the relative strength of its shares against the market has been %. At the current price of SEK3.2, shares in ChromoGenics AB are trading at 1.77% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the ChromoGenics AB PE Ratio?

We were not able to find PE ratio data for ChromoGenics AB.

Who are the key directors of ChromoGenics AB?

ChromoGenics AB's management team is headed by:

Anders Brannstrom - DRC
Peter Lundh - DSL
Greger Gregard - OTH
Micael Hamberg - COO
Claes-Goran Granqvist - DRC
Peter Gustafson - DRC
Mari Broman - DRC
Asa Stroofe - CMO
Christer Simren - CHM
Lars Ericsson - CFO
Leif Ljungqvist - CEO
Who are the major shareholders of ChromoGenics AB?

Here are the top five shareholders of ChromoGenics AB based on the size of their shareholding:

Similar to CHRO TO3
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.